论文部分内容阅读
目的探讨参麦注射液在恶性肿瘤患者化疗中的抗肿瘤作用和对肿瘤化疗的增效减毒作用。方法把101例患者随机分为两组,试验组(n=51)用化疗药物加参麦注射液,对照组(n=50)仅用化疗药物。结果试验组与对照组比较,试验组不良反应的发生率明显降低。且试验组除两位患者因自身状况停止化疗,其余如期完成化疗全过程,占96%,而对照组仅15%完成化疗全过程。结论在化疗同时加用参麦注射液,能增强肿瘤患者机体免疫功能,增强化疗药物疗效,减少化疗药物毒副反应。
Objective To investigate the anti-tumor effect of Shenmai injection in the chemotherapy of malignant tumor patients and its synergistic and attenuated effect on tumor chemotherapy. Methods 101 patients were randomly divided into two groups. The experimental group (n = 51) was treated with chemotherapeutic drugs plus Shenmai injection and the control group (n = 50) with chemotherapy alone. Results Compared with the control group, the incidence of adverse reactions in the experimental group decreased significantly. In addition to the two patients in the experimental group due to their own condition to stop chemotherapy, the rest completed the entire course of chemotherapy as scheduled, accounting for 96%, while only 15% of the control group completed the entire course of chemotherapy. Conclusions Chemotherapy combined with Shenmai injection can enhance the immune function of tumor patients, enhance the curative effect of chemotherapy drugs and reduce the side effects of chemotherapy drugs.